Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
2 Months : From Feb 2020 to Apr 2020
Gilead Sciences' chief medical officer, Merdad Parsey, said a patient's recovery after taking the company's drug could be an anecdote. "Gilead Sciences Scrambles to Supply Experimental Coronavirus Drug" at 10:52 a.m. ET, incorrectly quoted him saying it could be an antidote in the fourth paragraph. (Feb. 12, 2020)
(END) Dow Jones Newswires
February 12, 2020 13:27 ET (18:27 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.